Rosa
Del Campo is a research microbiologist at Instituto Ramón y Cajal
de Investigación Sanitaria, Madrid. She obtained her MD (1994) and a Ph.D.
(1998) from the University of Zaragoza. She is also a professor at Alfonso X el
Sabio University and a member of the board at the Spanish Society of
Microbiology (SEM) and SEIMC. Over her successful career, she has led several
international projects, received numerous awards, and published over one
hundred scientific manuscripts. She joined the Scientific Advisory Board of
Microviable Therapeutics in 2021 to advance clinical evidence of
microbiota-based biotherapeutic products.
Rosa
Del Campo is a research microbiologist at Instituto Ramón y Cajal
de Investigación Sanitaria, Madrid. She obtained her MD (1994) and a Ph.D.
(1998) from the University of Zaragoza. She is also a professor at Alfonso X el
Sabio University and a member of the board at the Spanish Society of
Microbiology (SEM) and SEIMC. Over her successful career, she has led several
international projects, received numerous awards, and published over one
hundred scientific manuscripts. She joined the Scientific Advisory Board of
Microviable Therapeutics in 2021 to advance clinical evidence of
microbiota-based biotherapeutic products.